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Abstract
The aim of the present study was to investigate metabolite alterations in the hippocampal formation
as they relate to aggression in high-functioning adults with autism. We measured concentrations of
N-acetylaspartate (NAA), choline-containing compounds (Cho), and creatine plus phosphocreatine (Cr+
PCr) in the hippocampal formation by proton magnetic resonance spectroscopy in 12 non-medicated male
subjects with autism and 12 age- and sex-matched controls. Aggression was scored in the autistic subjects
using the Buss–Perry Aggression Questionnaire. The concentrations of Cho and Cr+PCr in the hippo-
campal formation in autistic subjects were signiﬁcantly higher than the corresponding values in control
subjects, and a signiﬁcant positive correlation was observed between the concentrations of these metab-
olites in the hippocampal formation and scores on the Buss–Perry Aggression Questionnaire in autistic
subjects. Results suggest that high-functioning adult subjects with autism have abnormal metabolite
concentrations in the hippocampal formation, which may in part account for their aggression.
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Introduction
Autism is a neurodevelopmental disorder character-
ized by qualitative impairment of social interaction
and communication, as well as by restricted repetitive
and stereotyped patterns of behaviours, interests, and
activities. In addition to the core features of autism,
there are common comorbid psychiatric symptoms
such as anxiety, depression, and aggression (Matson &
Nebel-Schwalm, 2007). The presence of aggressive be-
haviour can reduce the eﬀectiveness of treatment in-
terventions, andmany individuals with autism remain
signiﬁcantly impaired. Therefore, from a treatment
perspective, it would be advantageous to clarify the
underlying mechanism for the development of ag-
gression in individuals with autism. The brain struc-
tures that are involved in the control of aggression
include limbic structures such as the amygdala, hip-
pocampus (Gregg & Siegel, 2001), and the cerebellum
(Berman, 1997). Interestingly, the most signiﬁcant
ﬁndings from post-mortem studies of autism have
been conﬁned to regions of the limbic system and the
cerebellum, e.g. reduced neuronal cell size and in-
creased cell packing density in the hippocampus
(Bauman & Kemper, 2005), shrinkage of nuclei of the
amygdala (Schumann & Amaral, 2006), and reduced
Purkinje cell density in the cerebellum (Bailey et al.
1998 ; Bauman & Kemper, 2005 ; Ritvo et al. 1986).
However, the correlation between structural abnor-
malities associated with dysfunction in these struc-
tures and aggression in autism has not yet been
clearly established.
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Proton magnetic resonance spectroscopy (1H-MRS)
is a non-invasive tool for evaluating neurochemical
changes related to the clinical characteristics of psy-
chiatric disorders. 1H-MRS produces spectra that rep-
resent concentrations of N-acetylaspartate (NAA), a
marker of neuronal integrity (Clark, 1998) ; choline-
containing compounds (Cho), markers of cell number
and/or membrane turnover (Miller et al. 1996) ; and
creatine plus phosphocreatine (Cr+PCr), a marker
of overall (i.e. neuronal plus glial) cellular density
(Sartorius et al. 2008). Of the 35 post-mortem cases of
autism reported in the previous studies mentioned
above, 26 had died aged o19 yr. It is expected that
1H-MRS study of the brain of autistic adults will be
a helpful initial step in clarifying the involvement of
the limbic system and cerebellum in the expression
of aggression by individuals with autism. However,
previous 1H-MRS studies of the limbic system and
cerebellum of autistic patients have primarily focused
on children (i.e. patients aged <20 yr) and have been
confounded by the inclusion of learning-disabled sub-
jects and subjects with seizure disorders. In this regard,
the only exception was a study by Page et al. (2006), in
which the authors examined high-functioning adults
with autism and reported a signiﬁcant increase in
Cr+PCr levels in the amygdala–hippocampal region.
However, in that study, the relationship between
neurobiological changes and clinical features was
not examined. Furthermore, the putative roles of the
amygdala and hippocampus in the expression of ag-
gression appeared to diﬀer (Gregg & Siegel, 2001),
although these two regions are closely interconnected.
To date, there has been no report of a 1H-MRS evalu-
ation of concentrations ofmetabolites in the cerebellum
of adult subjects with autism.
In the present study, we hypothesized that alter-
ations of metabolites may be present in the hippo-
campus and cerebellum of high-functioning adults
with autism, and such metabolite alterations could be
correlated with the aggression exhibited in a subset of
these patients. To test these hypotheses, we recruited
non-medicated, high-functioning male adults with
autism in order to measure metabolite concentrations
in the hippocampal formation (not including the
amygdala) and cerebellum of these subjects using
1H-MRS. In addition, we examined the correlation
between metabolite levels and aggression in autistic
adults.
Methods
The Ethics Committee of the Hamamatsu Univer-
sity School of Medicine approved the study. Each
participant gave written informed consent after
being given a complete description of the study. We
conducted the Wechsler Adult Intelligence Scale –
Revised (WAIS-R) to assess the intelligence quotient
(IQ) of all participants. The diagnosis of autism was
made according to the Japanese version of the Autism
Diagnostic Interview – Revised (ADI-R; Lord et al.
1994) and the Autism Diagnostic Observation Sched-
ule (ADOS; Lord et al. 2000). Control subjects were
recruited from the community by advertisement. All
autistic and control subjects were screened to exclude
psychiatric illnesses (i.e. schizophrenia, aﬀective dis-
orders, mental retardation, and personality or behav-
ioural disorders) by means of the Structured Clinical
Interview for DSM-IV (SCID). We excluded individ-
uals with epilepsy, with psychotropic medication,
and those with mental retardation as deﬁned by a full-
scale IQ of<70. Twelve male subjects with autism and
12 age-matched healthy male controls were included
in the present study. All participants were right-
handed, as assessed by the Edinburgh Handedness
Inventory (Oldﬁeld, 1971). We evaluated aggression
in the participants using the Japanese version of the
Aggression Questionnaire (Ando et al. 1999). The
original version of the Aggression Questionnaire (Buss
& Perry, 1992) is a 29-item, self-administered test de-
signed to measure aggression (i.e. physical aggression,
verbal aggression, anger, and hostility) as a person-
ality trait. The validity and reliability of the Japanese
version of the Aggression Questionnaire has pre-
viously been established (Ando et al. 1999).
Participants were scanned using a GE 1.5 T mag-
netic resonance scanner at the Hamamatsu University
Hospital. We selected two volumes of interest (VOIs)
for each subject, i.e. the left hippocampal region and
the right cerebellar hemisphere (Fig. 1a–c). The ration-
ale for the selection of two VOIs was as follows: (1)
since all the participants were right-handed, the left
hippocampus and the right cerebellum were regarded
as dominant (Jansen, 2005) ; (2) although there is no
known direct projection from the hippocampus to the
cerebellum, most of the eﬀerents from the temporo-
limbic region send information to the contralateral
cerebellar cortex via the cortico-ponto-cerebellar
pathway (Schmahmann, 2000) ; and (3) left-sided ab-
normalities have been associated with aggression in
humans (Tebartz van Elst et al. 2000 ; Zetzsche et al.
2007). To establish these VOIs, whole-brain images
were acquired with a 3D fast-spoiled gradient-echo
imaging protocol. A sagittal scout image was used to
select oblique coronal slices perpendicular to the long
axis of the hippocampal formation (Fig. 1a). A slanted
rectangular VOI (2r2r1.5 cm3) was selected such
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that it was aligned along the long axis of the hippo-
campus, starting just posterior to the amygdala
(Fig. 1a, b). The centre of the VOI was at the cornu
ammonis of the left hippocampus; as a result, the VOI
contained the hippocampus proper and a portion of
the parahippocampal gyrus. A cerebellar VOI (2r2r
2 cm3) was placed on one axial image, which showed
the full length of the middle cerebellar peduncle
(Fig. 1c). To explore metabolite levels in the cerebellar
cortex, we excluded the dentate nucleus from each
VOI; the medial side of the VOI was just adjacent to
the lateral margin of the dentate nucleus, which was
determined by axial T2-weighted images. A point-
resolved spectroscopy (PRESS) spectrum [repetition
time (TR)=1500 ms, echo time (TE)=144 ms, 256 av-
erages] was obtained after chemical shift selective
water suppression. To determine the tissue compo-
sition of the VOI, fast-spoiled gradient-echo images
were segmented into white matter, gray matter, and
cerebrospinal ﬂuid (CSF) using the software package
Dr View/Linux. We measured the concentrations of
NAA, Cho, and Cr+PCr using the LC model algor-
ithm and corrected the concentrations for the pro-
portion of CSF within the VOI.
Statistical analyses were performed using two-
tailed Student’s t test, Spearman’s r correlation co-
eﬃcient, and Bonferroni’s correction. The level of
signiﬁcance was set at p<0.05.
Results
The demographic characteristics of the autistic and
control subjects are shown in Table 1. There was no
signiﬁcant diﬀerence in the distribution of age or
full-scale IQ between the two groups, indicating that
subject matching was successful. As shown in Table 1,
there were no signiﬁcant inter-group diﬀerences in the
compositions of gray matter, white matter, and CSF
within either of the two VOIs. In the hippocampus, the
autistic group had signiﬁcantly higher concentrations
of Cho (p<0.001) and Cr+PCr (p<0.001) compared to
control subjects (Table 1). In the cerebellum, the con-
centration of NAA in the autistic group was signiﬁ-
cantly lower than that in the control group (p<0.001,
Table 1). We performed a Spearman’s correlation
analysis to determine whether the concentrations of
Cho and Cr+PCr in the hippocampus and NAA in
the cerebellum were correlated with autistic subjects’
scores on the Aggression Questionnaire. Both Cho (p=
0.008) and Cr+PCr (p<0.001) concentrations in the
hippocampus, but not the NAA concentration in the
cerebellum, were signiﬁcantly positively correlated
with the Aggression Questionnaire scores (Fig. 1d).
There was no correlation between metabolite alter-
ations (i.e. hippocampal Cho and Cr+PCr, and cer-
ebellar NAA) and IQ or autistic symptoms as assessed
by ADI-R (data not shown).
Discussion
In the present study, the observed increase in the
Cr+PCr concentration in high-functioning subjects
with autism was compatible with the results of a
previous 1H-MRS study by Page et al. (2006), who
measured the concentration of this metabolite combi-
nation in the right amygdala–hippocampal complex
in autistic adults of normal intelligence. We also found
an elevation of Cho in the hippocampal formation (not
including the amygdala) of high-functioning adults




























Fig. 1. (a–c) Locations of a 6-ml volume of interest (VOI) in the left hippocampus (a, b) and of an 8-ml VOI in the right
cerebellum (c). (d) Choline-containing compounds (2 ; Cho) and creatine plus phosphocreatine ($ ; Cr+PCr) concentrations
in the hippocampus of autistic subjects. Both values showed a signiﬁcant and positive correlation with the Aggression
Questionnaire score (Cho : r=0.719, p=0.008 ; Cr+PCr : r=0.884, p<0.001).
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study by Page et al. (2006) did not demonstrate such
changes in Cho level. The discrepancy between the
two studies presumably may reﬂect a diﬀerence in
VOI placement, i.e. the Page et al. study included the
amygdala, whereas our study did not. The 1H-MRS
Cho peak is known to be caused by free choline, phos-
phocholine (components of membrane synthesis), and
glycerophosphocholine (a product of the degradation
of membrane phosphatidylcholine). Therefore, an in-
crease in the Cho concentration has been interpreted
as representing increased membrane synthesis and/or
membrane disruption in processes including tumour
growth, demyelinization, and gliosis (Miller et al.
1996). An elevation of Cr+PCr on 1H-MRS reﬂects
high-energy phosphate metabolism (Sartorius et al.
2008). Therefore, the elevation of Cho and Cr+PCr
levels observed here suggests active, viable neuronal
turnover in the hippocampal region of autistic adults.
Previous structural MRI studies (Rojas et al. 2004;
Schumann et al. 2004) have demonstrated enlarged
hippocampal volume in autistic adults of normal in-
telligence. However, since in our sample no changes
were observed in the NAA concentration in the hip-
pocampal region, it remains unclear whether or not
elevated Cho and Cr+PCr levels are associated with
changes in hippocampal volume. Further studies are
required to clarify this issue.
Both Cho and Cr+PCr concentrations in the left
hippocampal region were signiﬁcantly and positively
correlated with trait aggression, as assessed by the
Aggression Questionnaire administered to our adult
subjects with autism. To the best of our knowledge,
this is the ﬁrst report to describe a link between
metabolite alterations in the hippocampal formation
and a clinical feature of autism. There is no available
data to account for the mechanism by which the hip-
pocampus aﬀects the trait of aggression in autism.
However, the accumulated evidence does suggest that
the hippocampal formation modulates aggression in
animals. For instance, electrical stimulation of the
Table 1. Demographic characteristics and 1H-MRS measurements of the hippocampus and cerebellum in subjects with
autism and controls
Control (n=12) Autism (n=12) t value p value
Age (yr) 22.3¡1.8 (19–24) 22.0¡2.2 (18–25) 0.384 0.705
Full-scale IQ 105.2¡12.6 (85–125) 96.3¡14.0 (71–117) 1.645 0.114
ADI-R (Diagnostic algorithm)
(A) Social n.a. 20.9¡5.3 (12–28)
(B) Communication
Verbal n.a. 14.2¡5.4 (4–22)
Non-verbal n.a. 8.4¡4.0 (2–14)
(C) Stereotype n.a. 5.5¡2.0 (3–10)
Aggression Questionnaire n.a. 45.3¡9.4 (34–64)
Hippocampus
NAA (IU) 7.79¡1.57 8.14¡0.84 x0.672 0.509
Cho (IU) 1.87¡0.21 2.19¡0.17 x4.176 <0.001*
Cr+PCr (IU) 3.80¡0.97 5.16¡0.59 x4.124 <0.001*
Gray matter (%) 64.5¡6.9 65.6¡7.3 0.394 0.866
White matter (%) 33.9¡8.3 32.2¡7.5 0.609 0.769
Cerebrospinal ﬂuid (%) 1.6¡2.0 2.2¡1.9 0.215 0.880
Cerebellum
NAA (IU) 9.01¡0.50 8.29¡0.71 3.949 <0.001*
Cho (IU) 2.12¡0.18 2.07¡0.22 0.505 0.618
Cr+PCr (IU) 6.08¡0.56 5.85¡0.63 0.909 0.373
Grey matter (%) 71.6¡9.2 71.8¡8.0 0.620 0.495
White matter (%) 28.2¡9.2 27.7¡8.9 0.154 0.448
Cerebrospinal ﬂuid (%) 0.0¡0.0 0.1¡0.0 0.031 0.084
ADI-R, Autism Diagnostic Interview – Revised; n.a., not applicable. NAA, N-acetylaspartate ; Cho, choline-containing
compounds ; Cr+PCr, creatine plus phosphocreatine ; IU, institutional unit.
Values are expressed as means¡S.D. (range).
* Statistically signiﬁcant diﬀerence, as determined by two-tailed Student’s t test.
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dorsal or ventral hippocampus has been shown to
inhibit or facilitate, respectively, aggressive behaviour
in cats (Gregg & Siegel, 2001). Electrophysiological
recordings have revealed that aggressive behaviours
are associated with increased frequency in hippocam-
pal discharge patterns in rabbits (Fontani & Vegni,
1990). Furthermore, the present ﬁndings agree with
the results of previous clinical studies indicating that
left hemispheric lesions may be associated with a
higher risk for the development of aggression (Tebartz
van Elst et al. 2000). Zetzsche et al. (2007) reported that
increased lifetime aggression in patients with border-
line personality disorder was signiﬁcantly correlated
with volume of the left, but not the right, hippocam-
pus. Taken together, these ﬁndings suggest that the
elevations in the Cho and Cr+PCr concentrations ob-
served here reﬂect altered function in the hippocampal
formation, which in turn was found to be associated
with aggression in adult subjects with autism. Since it
is still unclear whether the functional alterations in the
hippocampal formation are causative of aggression in
people with autism, further studies are needed.
As assessed by 1H-MRS, the concentration of NAA
in the cerebellum was signiﬁcantly lower in autistic
adults than controls. This ﬁnding is comparable with
that of previous 1H-MRS studies of autistic children,
who exhibited a similar reduction in metabolite con-
centrations in the cerebellum (Chugani et al. 1999 ;
Otsuka et al. 1999). Since post-mortem studies have
repeatedly demonstrated decreased Purkinje cell den-
sity in the cerebellum (Bailey et al. 1998 ; Bauman &
Kemper, 2005; Ritvo et al. 1986), and since a decrease
in the 1H-MRS NAA peak is a putative marker of
neuronal loss (Clark, 1998), it is possible that the de-
creased NAA concentration observed here reﬂects a
relative decrease in the number of Purkinje cells in the
cerebellum of high-functioning subjects with autism.
There are some limitations of our study. The small
sample size renders the data presented here prelimi-
nary, and a larger study with more subjects with
autism will be necessary. However, recruitment for
the present study was limited to a group of high-
functioning subjects with autism, all of whom were
given no psychotropic drugs, and all were able to
complete magnetic resonance spectroscopy without
sedation. Therefore, we believe that our data are free
from possible confounding factors and thus may re-
ﬂect a certain common pathology in people with
autism. Other limitations of this study include the
following: (1) the lack of an assessment of the right
hippocampal formation ; (2) inclusion of not only the
hippocampus proper, but also the parahippocampal
gyrus in the hippocampal VOI; and (3) a relatively
short TR acquisition period in the 1H-MRS method,
which could have aﬀected metabolite levels. Further-
more, we did not include autistic adults without
aggression as a comparison group, which might have
been useful to test our hypothesis. These limitations
should be factored into any interpretation of the
present results. Nevertheless, in the existing literature,
few studies to date have combined results from
neuropsychological tests with neurometabolic levels
in speciﬁc brain areas, which is a main advantage of
our study.
In conclusion, although the sample size was small,
our ﬁndings suggest that high-functioning people
with autism have metabolite alterations in the cer-
ebellum and hippocampus, and the latter in particular
may play an important role in the expression of ag-
gression in individuals with autism.
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